Par Drugs And Chemicals Limited

Par Drugs And Chemicals Limited (PAR) is a micro-cap Healthcare company valued at ₹135 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Par Drugs And Chemicals Limited last traded at ₹109.53, modestly down 1.52% on the day.

Recent developments

On 2026-06-30, the company reported its latest quarter results, showing a significant increase in both revenue and net profit compared to the same quarter a year earlier. Domestic institutional holding increased by 0.09 percentage points to 0.09% in the quarter, suggesting some institutional interest.

Financial performance

The company's annual revenue grew 2.6% year-over-year, while net profit remained flat at ₹13 crore. In the latest quarter, revenue rose 20.1% compared to the same quarter a year earlier, and net profit surged 41.4%, indicating stronger performance in the recent period despite a slight decline in the net profit margin to 12.6% from 12.9%.

Valuation multiples

The stock trades at 10.3 times earnings, a discount to the Healthcare median of 32.0, 1.55 times book value. It yields 0.9%.

Things to watch

The company's net profit margin narrowed by 0.2 percentage points to 12.6%, which could signal pressure on profitability. The stock is 31.1% below its 52-week high, indicating a notable decline from recent peak levels. Additionally, the company has not paid out dividends despite reporting repeated profits, which may affect investor appeal.

Where it stands

The company has shown growth in both revenue and net profit in the latest quarter, with net profit rising 41.4% year-over-year. However, the stock remains 31.1% below its 52-week high, and the net profit margin has slightly declined. The company's performance in the latest quarter highlights improving trends, but the lack of dividend payouts and the price drop from its peak are key factors to note.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.